A detailed history of Wedbush Securities Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wedbush Securities Inc holds 18,889 shares of EW stock, worth $1.24 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
18,889
Previous 18,604 1.53%
Holding current value
$1.24 Million
Previous $1.78 Million 1.86%
% of portfolio
0.06%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$84.3 - $94.31 $24,025 - $26,878
285 Added 1.53%
18,889 $1.75 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $44,612 - $58,769
-615 Reduced 3.2%
18,604 $1.78 Million
Q4 2023

Feb 12, 2024

SELL
$61.71 - $77.76 $22,832 - $28,771
-370 Reduced 1.89%
19,219 $1.47 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $70,873 - $95,527
-1,023 Reduced 4.96%
19,589 $1.36 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $263,361 - $305,157
-3,235 Reduced 13.57%
20,612 $1.94 Million
Q1 2023

May 09, 2023

SELL
$74.26 - $84.51 $217,581 - $247,614
-2,930 Reduced 10.94%
23,847 $1.97 Million
Q4 2022

Jan 31, 2023

SELL
$68.3 - $87.44 $171,501 - $219,561
-2,511 Reduced 8.57%
26,777 $2 Million
Q3 2022

Oct 18, 2022

BUY
$82.37 - $107.29 $68,284 - $88,943
829 Added 2.91%
29,288 $2.42 Million
Q2 2022

Jul 21, 2022

SELL
$86.5 - $128.27 $101,551 - $150,588
-1,174 Reduced 3.96%
28,459 $2.71 Million
Q1 2022

Apr 19, 2022

BUY
$101.96 - $128.34 $45,576 - $57,367
447 Added 1.53%
29,633 $3.49 Million
Q4 2021

Jan 13, 2022

BUY
$106.37 - $130.68 $656,622 - $806,687
6,173 Added 26.82%
29,186 $3.78 Million
Q3 2021

Oct 08, 2021

BUY
$102.91 - $122.75 $53,307 - $63,584
518 Added 2.3%
23,013 $2.61 Million
Q2 2021

Jul 27, 2021

BUY
$83.84 - $104.76 $429,596 - $536,790
5,124 Added 29.5%
22,495 $2.33 Million
Q1 2021

Apr 26, 2021

BUY
$78.68 - $90.67 $161,766 - $186,417
2,056 Added 13.42%
17,371 $1.45 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $155,423 - $197,786
-2,168 Reduced 12.4%
15,315 $1.4 Million
Q3 2020

Oct 20, 2020

BUY
$67.19 - $87.44 $6,517 - $8,481
97 Added 0.56%
17,483 $1.4 Million
Q2 2020

Jul 16, 2020

BUY
$57.54 - $76.95 $684,668 - $915,628
11,899 Added 216.86%
17,386 $1.2 Million
Q1 2020

Apr 17, 2020

BUY
$52.41 - $81.0 $25,366 - $39,204
484 Added 9.67%
5,487 $1.04 Million
Q4 2019

Jan 16, 2020

BUY
$71.7 - $82.09 $22,442 - $25,694
313 Added 6.67%
5,003 $1.17 Million
Q3 2019

Oct 17, 2019

SELL
$61.55 - $75.43 $1,538 - $1,885
-25 Reduced 0.53%
4,690 $1.03 Million
Q2 2019

Aug 01, 2019

SELL
$55.74 - $64.41 $8,918 - $10,305
-160 Reduced 3.28%
4,715 $871,000
Q1 2019

Apr 17, 2019

BUY
$47.89 - $64.05 $19,395 - $25,940
405 Added 9.06%
4,875 $933,000
Q4 2018

Jan 31, 2019

BUY
$46.41 - $56.94 $67,758 - $83,132
1,460 Added 48.5%
4,470 $685,000
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $1,096 - $1,392
24 Added 0.8%
3,010 $524,000
Q2 2018

Aug 03, 2018

SELL
$42.45 - $51.3 $56,203 - $67,921
-1,324 Reduced 30.72%
2,986 $435,000
Q1 2018

May 01, 2018

SELL
$37.19 - $47.45 $128,193 - $163,560
-3,447 Reduced 44.44%
4,310 $601,000
Q4 2017

Feb 09, 2018

BUY
$33.79 - $39.39 $9,123 - $10,635
270 Added 3.61%
7,757 $874,000
Q3 2017

Oct 31, 2017

BUY
$36.29 - $38.83 $271,703 - $290,720
7,487
7,487 $818,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.